This corona vaccine can make the Indian company rich after successful in the test
This corona vaccine can make the Indian company rich after successful in the test
Share:

Renu Swarup, secretary of the Department of Biotechnology of India on Thursday told that testing indigenously developed medicine for Covid-19 on humans is a milestone in the direction of self-reliant India. Renu Swarup said that human trials of indigenously developed Corona drugs have started. Zydus Cadila's step is very important in the direction of self-reliant India.

Zydus Cadila said on Wednesday that it has started human trials of his corona medicine. Under this, Stage-1 and Stage-2 of human trials have been started. The plasmid DNA drug ZyCoV-D is designed and manufactured by Zydus Cadila. The same, ZyCoV-D is partially funded by the Department of Biotechnology under the National Biopharma Mission.

It is to be noted that the DBT Secretary stated in a statement that it is the first indigenously developed drug for coronavirus spreading in humans in India. Renu Swarup said that this is also a big leap for the scientific community of India. He said that the indigenously developed corona drug of Zydus Cadila has started human trials, which is a milestone for self-reliant India. We hope that the corona drug gives good results in human trials just like pre-clinical trials. This drug was found to be safe, immunogenic, and qualified in pre-clinical trials.

Also Read:

Samsung Galaxy M01s launched, know features

A country where three people become presidents in just one hourKapil Sharma did wonder with his comedy, Fan thank him

Silver shines brighter than gold, know today's rates

Join NewsTrack Whatsapp group
Related News